Research Forensic Library
A program of the Global Forensic and Justice Center at Florida International University
Center for Forensic Science Research & Education
| Title | Authors | Source | Link | Year |
|---|---|---|---|---|
| Drug Checking Quarterly Report (Q1 and Q2 2023): Philadelphia, PA, USA | Joshua DeBord, Jen Shinefeld, Rachel Russell, Max Denn, Alexis Quinter, Barry K. Logan, Daniel Teixeira da Silva, and Alex J. Krotulski | Center for Forensic Science Research and Education; December 2023 | www.cfsre.org/nps-discovery/drug-checking?emci=e291fe14-4d90-ee11-8925-002248223f36&emdi=801f2d4c-5a90-ee11-8925-002248223f36&ceid=8116689 | 2023 |
| Recommended Scope for NPS Testing in the United States – Q4 2023 | Alex Krotulski, Donna Papsun, Dani Mata, Kayla Ellefsen, Elisa Shoff, Szabolcs Sofalvi, Svante Vikingsson, Michael Truver, Celia Modell, Lana Goodson, and Barry Logan | Center for Forensic Science Research and Education; 2023 | www.cfsre.org/nps-discovery/scope-recommendations | 2023 |
| Brodifacoum in Synthetic Cannabinoids | Mia Borrelli, M.S., Amanda L.A. Mohr, M.S., Thom Browne, and Barry K. Logan, Ph.D. | CFSRE; August 2023 | www.cfsre.org/images/content/reports/public_alerts/Brodifacoum_Public_Health_Alert_Final.pdf | 2023 |
| Colombo Plan Bulletin: Worldwide Trends in Drug Markets and Toxic Adulterants | M.J. Menendez, Barry K. Logan, Ph.D. & Thom Browne, MA | CFSRE; August 2023 | www.cfsre.org/nps-discovery/public-alerts/colombo-plan-bulletin-worldwide-trends-in-drug-markets-and-toxic-adulterants | 2023 |
| New Nitazene Analogue N-Pyrrolidino Protonitazene Impacting Drug Markets In North America and Europe | Krotulski, AJ; Walton, SE; Papsun, DM; DeBord, J; Fogarty, MF; Logan, BK | CFSRE; August 2023 | www.cfsre.org/nps-discovery/public-alerts | 2023 |
| Counterfeit Captagon – Colombo Plan Health Alert | Barry K. Logan, Ph.D. Amanda L.A. Mohr, M.S., & Thom Browne MA. | CFSRE; August 2023 | www.cfsre.org/nps-discovery/public-alerts/counterfeit-captagon-a-colombo-plan-health-alert | 2023 |
| Recommended Scope for NPS Testing in the United States – Quarter 3 | Alex Krotulski, Donna Papsun, Dani Mata, Kayla Ellefsen, Elisa Shoff, Szabolcs Sofalvi, Svante Vikingsson, Michael Truver, Celia Modell, and Barry Logan | CFSRE; August 2023 | www.cfsre.org/nps-discovery/scope-recommendations | 2023 |
| Q2 2023 Trend Reports – NPS Benzodiazepines, NPS Opioids, NPS Stimulants & Hallucinogens, and Synthetic Cannabinoids in the U.S. | Alex J. Krotulski, PhD; Sara E. Walton, MS; Amanda L.A. Mohr, MSFS, D-ABFT-FT; and Barry K. Logan, PhD, F-ABFT | CFSRE; July 2023 | www.cfsre.org/nps-discovery/trend-reports?emci=b28c5760-391c-ee11-a9bb-00224832eb73&emdi=14fdb3a2-ce1c-ee11-a9bb-00224832eb73&ceid=8113231 | 2023 |
| Recommended Scope for NPS Testing in the United States: Q2, 2023 | Alex Krotulski, Donna Papsun, Dani Mata, Kayla Ellefson, Elisa Shoff, Szabolcs Sofalvi, Svanto Vikingsson, Michael Truver, Celia Modoll, and Barry Logan | CFSRE; May 2023 | www.cfsre.org/nps-discovery/scope-recommendations | 2023 |
| ToxIC Fentalog Study Group – Quarterly NPS Report: Q2 2023 | Alex Manini, Alex Krotulski, Sara Walton, Paul Wax, Jeffery Brent, Kim Aldy, Rachael Culbreth, Joseph Carpenter, Alexandra Amaducci, Jennie Buchanan, Bryan Judge, Michael Levine, Diane Calello, Joshua Shulman, Rob Hendrickson, Adrienne Hughes, Barry Logan | CFSRE; May 2023 | www.cfsre.org/nps-discovery/clinical-reports | 2023 |
| ToxIC Fentalog Study Group – Quarterly NPS Report: Q1 2023 | Alex Manini, Alex Krotulski, Sara Walton, Paul Wax, Jeffery Brent, Kim Aldy, Rachael Culbreth, Joseph Carpenter, Alexandra Amaducci, Jennie Buchanan, Bryan Judge, Michael Levine, Diane Calello, Joshua Shulman, Rob Hendrickson, Adrienne Hughes, Barry Logan | CFSRE; May 2023 | www.cfsre.org/nps-discovery/clinical-reports | 2023 |
| ADB-5’Br-PINACA – New drug monograph | Alex J. Krotulski, Osama Abdallah Sharif Alyamani, Maha Elgid, Sara E. Walton, Josh DeBord, Melissa F. Fogarty, and Barry K. Logan | CFSRE; May 1, 2023 | www.cfsre.org/nps-discovery/monographs | 2023 |
| NPS Benzodiazepines, NPS Opioids, NPS Stimulants & Hallucinogens, and Synthetic Cannabinoids in the United States – Q1 2023 Trend Report | Alex J. Krotulski, PhD; Sara E. Walton, MS; Amanda L.A. Mohr, MSFS, D-ABFT-FT; and Barry K. Logan, PhD, F-ABFT | CFSRE; April 2023 | www.cfsre.org/nps-discovery/trend-reports | 2023 |
| Phenylbutazone: A Toxic Adulterant Found in Illicit Street Drugs | Sarah A. Shuda, M.S., Amanda L.A. Mohr, M.S., Thom Browne, and Barry K. Logan, Ph.D. | CFSRE; March 2023 | www.cfsre.org/nps-discovery/public-alerts/phenylbutazone-toxic-adulterants-found-in-illicit-street-drugs | 2023 |
| Evaluation of Xylazine Test Strips (BTNX) for Drug Checking Purposes | Krotulski, AJ; Shinefeld, J; DeBord, J; Teixeira da Silva, D; Logan, BK. | CFSRE; 2023 | www.cfsre.org/nps-discovery/drug-checking/evaluation-of-xylazine-test-strips-btnx-for-drug-checking-purposes | 2023 |
| Recommended Scope for NPS Testing in the United States: Q1 2023 | Alex Krotulski, Donna Papsun, Dani Mata, Kayla Ellefson, Elisa Shoff, Szabolcs Sofalvi, Svanto Vikingsson, Michael Truver, Celia Modoll, and Barry Logan | SOFT, CFSRE; February 2023 | www.cfsre.org/nps-discovery/scope-recommendations | 2023 |
| N-Desethyl Isotonitazene | Alex J. Krotulski, PhD; Reta Newman, MA; Michael Gilbert, BS; Sara E. Walton, MS; Melissa F. Fogarty, MSFS, D-ABFT-FT; and Barry K. Logan, PhD, F-ABFT | CFSRE; December 20, 2022 | www.cfsre.org/nps-discovery/monographs | 2022 |
| Drug Checking Quarterly Report – Q3 2022 | Alex J. Krotulski, PhD; Jen Shinefeld, MS; Joshua DeBord, PhD; Daniel Teixeira da Silva, MD; and Barry K. Logan, PhD, F-ABFT | CFSRE, PDPH; November 2022 | www.cfsre.org/nps-discovery/drug-checking/drug-checking-q3-2022-philadelphia-pennsylvania-usa | 2022 |
| ToxIC Fentalog Study Group – Quarterly NPS Report – Q3 | Alex Manini, MD; Alex J Krotulski, PhD; Sara E. Walton, MS; Paul Wax, MD; Jeffery Brent, MD, PhD; Kim Aldy, DO; Alexandra Amaducci, DO; Dlane Calello, MD; Adrienne Hughes, MD; Anthony Pizon, MD; Michael Levine, MD; Evan Schwarz, MD; Bryan Judge, MD; and Barry K. Logan, PhD, F-ABFT | CSFRE; TIC; ACMT; October 2022 | www.cfsre.org/nps-discovery/clinical-reports | 2022 |
| NPS Discovery Toolkit: N-Pyrrolidino Etonitazene | Sara E. Walton, MS; Alex J. Krotulski, PhD; Melissa F. Fogarty, MSFS, D-ABFT-FT; Donna M. Papsun, MS, D-ABFT; and Barry K. Logan, PhD, F-ABFT | CFSRE; October 2022 | www.cfsre.org/nps-discovery/analytical-toolkits | 2022 |
| NPS Benzodiazepines in the United States – Q3 Trend Report | Alex J. Krotulski, PhD; Sara E. Walton, MS; Amanda L.A. Mohr, MSFS, D-ABFT-FT; and Barry K. Logan, PhD, F-ABFT | CFSRE; October 2022 | www.cfsre.org/nps-discovery/trend-reports/nps-benzodiazepines/report/49?trend_type_id=1 | 2022 |
| Fentanyl Purity, Potency, & Synthesis: Real-Time Testing of Opioid Drug Products in the United States | Krotulski, AJ, Shinefeld, J, DeBord, J, Logan, BK | CFSRE; August, 2022 | www.npsdiscovery.org/fentanyl-purity-potency-synthesis-real-time-testing-of-opioid-drug-products-in-the-united-states/ | 2022 |
| Recommended Scope for NPS Testing in the United States: Q2 2022 | Alex Krotulski, Donna Papsun, Dani Mata, Kayla Ellefsen, Elisa Shoff, Kevin Shanks, Szabolcs Sofalvi, Wayne Lewallen, Svante Vikingsson, and Barry Logan | CFSRE; July 2022 | www.npsdiscovery.org/reports/nps-scope-recommendations/ | 2022 |
| N-Propyl Butylone | Alex J. Krotulski, PhD; Vanquilla Shellman Francis, PhD; Melissa F. Fogarty, MSFS, D-ABFTFT; Sara E. Walton, MS; and Barry K. Logan, PhD, F-ABFT | CFSRE; July 21, 2022 | www.npsdiscovery.org/reports/monographs/ | 2022 |
| NPS Benzodiazepines, NPS Opioids, NPS Stimulants & Hallucinogens, and Synthetic Cannabinoids – Q2 2022 Trend Reports | Alex J. Krotulski, PhD; Sara E. Walton, MS; Amanda L.A. Mohr, MSFS, D-ABFT-FT; and Barry K. Logan, PhD, F-ABFT | CFSRE; July 13, 2022 | www.npsdiscovery.org/reports/trend-reports/ | 2022 |
| CH-FUBIATA | Alex J. Krotulski, PhD; Jennifer Shinefeld, MS; Melissa F. Fogarty, MSFS, D-ABFT-FT; Joshua DeBord, PhD; and Barry K. Logan, PhD, F-ABFT | CFSRE; June 21, 2022 | www.npsdiscovery.org/reports/monographs/ | 2022 |
| Bromazolam Prevalence Surging Across the United States Driven In Part by Increasing Detections Alongside Fentanyl | Donna M. Papsun, MS, D-ABFT-FT; Alex J. Krotulski, PhD; Rebecca Mastrovito, MS; Sara E. Walton, MS; and Barry K. Logan, PhD, F-ABFT | CFSRE; June 15, CFSRE; June 15, 2022 | www.npsdiscovery.org/bromazolam-prevalence-surging-across-the-united-states-driven-in-part-by-increasing-detections-alongside-fentanyl/ | 2022 |
| N-Cyclohexyl Butylone | Alex J. Krotulski, PhD; Vanquilla Shellman Francis, PhD; Ryan Farrell; Zackery Roberson, PhD; Melissa F. Fogarty, MSFS, D-ABFT-FT; Sara E. Walton, MS; and Barry K. Logan, PhD, F-ABFT | CFSRE; June 9, 2022 | www.npsdiscovery.org/reports/monographs/ | 2022 |
| Drug Checking (Q2 2022): Philadelphia, Pennsylvania, USA | Alex J. Krotulski, PhD; Jen Shinefeld, MS; Jeffrey Hom, MD, MPH; Sara E. Walton, BS; Joshua DeBord, PhD; Barry K. Logan, PhD, F-ABFT | CFSRE; June 7, 2022 | www.npsdiscovery.org/drug-checking-q2-2022-philadelphia-pennsylvania-usa/ | 2021 |
| ADB-5’Br-BINACA | Alex J. Krotulski, PhD; Jennifer Shinefeld, MS; Robert M. Schelkun, MS; Donna M. Iula, PhD; Melissa F. Fogarty, MSFS, D-ABFT-FT; Joshua DeBord, PhD; and Barry K. Logan, PhD, F-ABFT | CFSRE; May 26, 2022 | www.npsdiscovery.org/wp-content/uploads/2022/05/ADB-5Br-BINACA_055622_CFSRE-Chemistry_Report.pdf | 2022 |
| BZO-4en-POXIZID | Alex J. Krotulski, PhD; Ryan Farrell; Armando Vargas; Melissa F. Fogarty, MSFS, DABFT-FT; Sara E. Walton, MS; and Barry K. Logan, PhD, F-ABF | CFSRE; May 19, 2022 | www.npsdiscovery.org/reports/monographs/ | 2022 |
| Recommended Scope for NPS Testing in the United States – Q1 2022 | Alex Krotulski, Donna Papsun, Dani Mata, Kayla Ellefsen, Elisa Shoff, Kevin Shanks, Szabolcs Sofalvi, Wayne Lewallen, Svante Vikingsson, and Barry Logan | CFSRE; May 12, 2022 | www.npsdiscovery.org/reports/nps-scope-recommendations/ | 2022 |
| N-Cyclohexyl Methylone | Alex J. Krotulski, PhD; Vanquilla Shellman Francis, PhD; Ryan Farrell; Kaitlin Schilde, MSFS; Melissa F. Fogarty, MSFS, D-ABFT-FT; Sara E. Walton, MS; and Barry K. Logan, PhD, F-ABFT | CFSRE; May 9, 2022 | www.npsdiscovery.org/wp-content/uploads/2022/05/N-Cyclohexyl-Methylone_050922_CFSRE-Chemistry_Report.pdf | 2022 |
| ADB-5Br-INACA | Alex J. Krotulski, PhD; Ryan Farrell; Zackery Roberson, PhD; Melissa F. Fogarty, MSFS, D-ABFT-FT; Sara E. Walton, MS; and Barry K. Logan, PhD, F-ABFT | CFSRE; May 17, 2022 | www.npsdiscovery.org/wp-content/uploads/2022/05/ADB-5Br-INACA_051721_CFSRE-Chemistry_Report.pdf | 2022 |
| MDMB-5Br-INACA | Alex J. Krotulski, PhD; Ryan Farrell; Kaitlin Schilde, MSFS; Melissa F. Fogarty, MSFS, D-ABFT-FT; Sara E. Walton, MS; and Barry K. Logan, PhD, F-ABFT | CFSRE; May 17, 2022 | www.npsdiscovery.org/wp-content/uploads/2022/05/MDMB-5Br-INACA_051721_CFSRE-Chemistry_Report.pdf | 2022 |
| CH-PIATA | Alex J. Krotulski, PhD; Ryan Farrell; Amanda Mohaupt, MSFS; Melissa F. Fogarty, MSFS, D-ABFT-FT; Sara E. Walton, MS; and Barry K. Logan, PhD, F-ABFT | CFSRE; April 29, 2022 | www.npsdiscovery.org/wp-content/uploads/2022/04/CH-PIATA_042922_CFSRE-Chemistry_Report.pdf | 2021 |
| Synthetic Stimulant Market Rapidly Changing as N,N-Dimethylpentylone Replaces Eutylone in Drug Supply Typically Sold as “Ecstasy” or “Molly” | Alex J. Krotulski, PhD; Melissa F. Fogarty, MS, D-ABFT-FT; Donna M. Papsun, MS, D-ABFT-FT; Michael Lamb, MS, D-ABFT-FT; Sara E. Walton, MS; and Barry K. Logan, PhD, F-ABFT | CFSRE; April 2022 | www.npsdiscovery.org/reports/public-health-alerts/ | 2022 |
| Synthetic Cannabinoids in the United States: Trend Report: Q1, 2022 | Alex J. Krotulski, PhD; Sara E. Walton, MS; Amanda L.A. Mohr, MSFS, D-ABFT-FT; and Barry K. Logan, PhD, F-ABFT | CFSRE; April 2022 | www.npsdiscovery.org/reports/trend-reports/ | 2022 |
| Drug Checking Report – Q1 2022: Philadelphia, Pennsylvania, USA | Alex J. Krotulski, PhD; Jen Shinefeld, MS; Jeffrey Hom, MD, MPH; Sara E. Walton, MS; and Barry K. Logan, PhD, F-ABFT | CSFRE; March 22, 2022 | www.npsdiscovery.org/reports/drug-checking/ | 2022 |
| N,N-Dimethylpentylone | Alex J. Krotulski, PhD; Sara E. Walton, MS; Melissa F. Fogarty, MSFS, DABFT- FT; Donna M. Papsun, MS, D-ABFT; Barry K. Logan, PhD, F-ABFT | Center for Forensic Science Research and Education; December 17, 2021 | www.npsdiscovery.org/wp-content/uploads/2021/12/NN-Dimethylpentylone_121721_CFSRE-Toxicology_Report.pdf | 2021 |
| Adverse Effects Linked to Next Generation Opioids Reported in Patients Presenting to Emergency Departments After Suspected Opioid Overdose | Alex Manini, MD; Alex J. Krotulski, PhD; Sara E. Walton, MS; Paul Wax, MD; Jeffery Brent, MD, PhD; Kim Aldy, DO; Diane Calello, MD; Alexandra Amaducci, DO; Evan Schwarz, MD; Bryan Judge, MD; Michael Levine, MD; Barry K. Logan, PhD, F-ABFT | Center for Forensic Science Research and Education; December 3, 2021 | www.npsdiscovery.org/adverse-effects-linked-to-next-generation-opioids-reported-in-patients-presenting-to-emergency-departments-after-suspected-opioid-overdose/ | 2021 |
| N-Piperidinyl Etonitazene | Alex J. Krotulski, PhD; Alex Manini, MD; Diane Calello, MD; Jeff Brent, MD, PhD; Paul Wax, MD; Kim Aldy, MD; Sara E. Walton, MS; Melissa F. Fogarty, MSFS, D-ABFT-FT; and Barry K. Logan, PhD, F-ABFT | Center for Forensic Science Research and Education; November 22, 2021 | www.npsdiscovery.org/wp-content/uploads/2021/11/N-Piperidinyl-Etonitazene_112221_ToxicologyAnalyticalReport.pdf | 2021 |
| ADB-PHETINACA | Alex J. Krotulski, PhD; Alex Manini, MD; Diane Calello, MD; Jeff Brent, MD, PhD; Paul Wax, MD; Kim Aldy, MD; Sara E. Walton, MS; Melissa F. Fogarty, MSFS, D-ABFT-FT; and Barry K. Logan, PhD, F-ABFT | Center for Forensic Science Research and Education; November 19, 2021 | www.npsdiscovery.org/wp-content/uploads/2021/11/ADB-PHETINACA_111921_ToxicologyAnalyticalReport.pdf | 2021 |
| BZO-CHMOXIZID | Alex J. Krotulski, PhD; Ryan Farrell; Amanda Mohaupt; Melissa F. Fogarty, MSFS, DABFT- FT; and Barry K. Logan, PhD, F-ABFT | NPS Discovery Center for Forensic Science Research and Education; November 18, 2021 | www.npsdiscovery.org/wp-content/uploads/2021/11/BZO-CHMOXIZID_111821_CFSRE-Chemistry_Report.pdf | 2021 |
| ADB-FUBIATA | Alex J. Krotulski, PhD; Ryan Farrell; Kaitlin Schilde; Robert M. Schelkun, MS; Donna M. Iula, PhD; Melissa F. Fogarty, MSFS, D-ABFT-FT; and Barry K. Logan, PhD, F-ABFT | Center for Forensic Science Research and Education; November 17, 2021 | www.npsdiscovery.org/wp-content/uploads/2021/11/ADB-FUBIATA_111721_CFSRE-Chemistry_Report.pdf | 2021 |
| BZO-HEXOXIZID | Alex J. Krotulski, PhD; Ryan Farrell; Zackery Roberson; Armando Vargas; Melissa F. Fogarty, MSFS, D-ABFT-FT; and Barry K. Logan, PhD, F-ABFT | Center for Forensic Science Research and Education; October 19, 2021 | www.npsdiscovery.org/wp-content/uploads/2021/10/BZO-HEXOXIZID_101921_CFSRE-Chemistry_Report.pdf | 2021 |
| 5F-BZO-POXIZID | Alex J. Krotulski, PhD; Reta Newman, MA; Michael Gilbert, BS; Melissa F. Fogarty, MSFS, D-ABFT-FT; and Barry K. Logan, PhD, F-ABF | Center for Forensic Science Research and Education; October 19, 2021 | www.npsdiscovery.org/wp-content/uploads/2021/10/5F-BZO-POXIZID_101921_CFSRE-Chemistry_Report.pdf | 2021 |
| Synthetic Cannabinoids in the United States | Alex J. Krotulski, PhD; Sara E. Walton, MS; Amanda L.A. Mohr, MSFS, D-ABFT-FT; Barry K. Logan, PhD, F-ABFT | Center for Forensic Science Research and Education; October 13, 2021 | www.npsdiscovery.org/wp-content/uploads/2021/10/2021-Q3_Synthetic-Cannabinoids_Trend-Report.pdf | 2021 |
| Fluclotizolam | Alex J. Krotulski, PhD; Sara E. Walton, MS; Donna M. Papsun, MS, D-ABFT-FT; Melissa F. Fogarty, MSFS, D-ABFT-FT; Barry K. Logan, PhD, F-ABFT | CSFRE; November 5 | www.npsdiscovery.org/reports/monographs/ | 2021 |
| Recommended Scope for NPS Testing in the United States: Q3 2021 | A Krotulski, D Papsun, D Mata, K Ellefsen, E Shoff, K Shanks, S Sofalvi, S Kacinko, W Lewallen, S Vikingsson, B Logan | CFSRE; Quarter 3, November | www.npsdiscovery.org/reports/nps-scope-recommendations/ | 2021 |
| Drug Supply Assessment: Q3 2021 – Philadelphia, Pennsylvania | Alex J. Krotulski, PhD; Jen Shinefeld, MS; et al | Center for Forensic Science Research and Education; October 2021 | www.npsdiscovery.org/drug-supply-assessment-q3-2021-philadelphia-pennsylvania-usa/ | 2021 |
| Metodesnitazene | Alex J. Krotulski, PhD; Matthew Juhascik, PhD, F-ABFT et al | The Center for Forensic Science Research and Education; September 2021 | t.co/YUsxge5hEy?amp=1 | 2021 |
| New Systematic Naming for Synthetic Cannabinoid “MDA-19” and Its Related Analogues: BZO-HEXOXIZID, 5F-BZO-POXIZID, and BZO-POXIZID | RM Schelkun, MS; AJ Krotulski, PhD; DM Iula, PhD; BK Logan, PhD, F-ABFT | CFSRE; Cayman Chemical; NPS Discovery; August 31, 2021 | www.npsdiscovery.org/wp-content/uploads/2021/08/New-Systematic-Naming-for-MDA-19-and-Related-Analogues_NPS-Discovery_083121.pdf | 2021 |
Global Forensic and Justice Center
11200 SW 8th Street
Miami, FL 33199
Contact Us